Sudarshan Chemical reported a strong Q1 FY27 with significant margin expansion driven by its Heubach pigment portfolio. Following the results, brokerage Anand Rathi raised its target price to ₹1,450 while maintaining a 'Buy' rating. The company also reported a notable reduction in net debt.
Sudarshan Chemical Industries reported strong financial results for the first quarter of the 2027 fiscal year, led by improved profit margins across its core business and the successful integration of its global Heubach pigment operations. The company’s consolidated revenue for the quarter reached ₹2,642.1 crore, marking a 5.4% increase compared to the same period last year. Profitability improved significantly, with EBITDA margins rising to approximately 9.8%, up from 7.7% in the corresponding quarter of the previous year.
The performance was supported by a recovery in the Heubach portfolio, which recorded an EBITDA margin of 7.4%, compared to 4.1% a year ago. The legacy pigment division also maintained strong operations with a 17.3% margin. These combined efforts helped the overall pigment business achieve a 10.3% margin, aided by better product yields and savings on utility costs.
A key focus for the company has been debt reduction. Sudarshan Chemical successfully lowered its net debt to ₹531 crore, a significant improvement from its peak levels of ₹922 crore. This trend of reducing debt is a critical factor for investors evaluating the company's financial stability as it pursues its expansion strategy.
Following these results, brokerage firm Anand Rathi reiterated its positive view on the stock, raising its target price to ₹1,450. Analysts noted that the company is seeing benefits from combining the Heubach operations with its own, including better manufacturing efficiency and rationalized spending. The potential for reclaiming lost customer accounts also adds to the positive outlook.
Management has provided clear financial targets for the future. For the current fiscal year, the company aims for a consolidated revenue between ₹98,000 crore and ₹102,000 crore, with a target EBITDA of ₹8,000 crore and net debt capped at ₹5,000 crore. Looking toward fiscal year 2029, the long-term goal is to reach a revenue range of ₹120,000 crore to ₹140,000 crore with a target EBITDA of ₹14,000 crore to ₹15,000 crore.
Despite the positive performance, investors should watch for potential risks. The chemical industry currently faces challenges such as volatile freight costs and geopolitical issues that could affect supply chains. Additionally, the success of the long-term growth plan depends on the smooth execution of the integration of global pigment operations. The company also carries a level of finished goods inventory that investors should track to understand if it aligns with actual demand trends. Future updates on how the company manages these logistics and integration risks will be important for assessing sustained profitability.